ArticleFrontiers in physiology2022

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway.

Xiaochen Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.